BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27249727)

  • 1. Issues in Breast Cancer Survivorship: Optimal Care, Bone Health, and Lifestyle Modifications.
    Melisko ME; Gradishar WJ; Moy B
    Am Soc Clin Oncol Educ Book; 2016; 35():e22-9. PubMed ID: 27249727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of lifestyle factors on prognosis among breast cancer survivors in the USA.
    Ellsworth RE; Valente AL; Shriver CD; Bittman B; Ellsworth DL
    Expert Rev Pharmacoecon Outcomes Res; 2012 Aug; 12(4):451-64. PubMed ID: 22971032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer survival among young women: a review of the role of modifiable lifestyle factors.
    Brenner DR; Brockton NT; Kotsopoulos J; Cotterchio M; Boucher BA; Courneya KS; Knight JA; Olivotto IA; Quan ML; Friedenreich CM
    Cancer Causes Control; 2016 Apr; 27(4):459-72. PubMed ID: 26970739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Survivorship and Models of Survivorship Care: A Review.
    Miller KD; Pandey M; Jain R; Mehta R
    Am J Clin Oncol; 2015 Dec; 38(6):627-33. PubMed ID: 25635609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.
    Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26631176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer survivorship and surveillance.
    Odle TG
    Radiol Technol; 2011; 83(1):63M-87M. PubMed ID: 21908782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifiable risk factors for breast cancer recurrence: what can we tell survivors?
    Norman SA; Potashnik SL; Galantino ML; De Michele AM; House L; Localio AR
    J Womens Health (Larchmt); 2007 Mar; 16(2):177-90. PubMed ID: 17388734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer in women younger than 40 years.
    Rosenberg R; Levy-Schwartz R
    Int J Fertil Womens Med; 2003; 48(5):200-5. PubMed ID: 14626376
    [No Abstract]   [Full Text] [Related]  

  • 9. Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
    Wilson S; Speers C; Tyldesley S; Chia S; Kennecke H; Ellard S; Lohrisch C
    Clin Breast Cancer; 2016 Aug; 16(4):284-90. PubMed ID: 26705158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone health in breast cancer survivors.
    Abdel-Razeq H; Awidi A
    J Cancer Res Ther; 2011; 7(3):256-63. PubMed ID: 22044804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system.
    Fehrenbacher L; Capra AM; Quesenberry CP; Fulton R; Shiraz P; Habel LA
    J Clin Oncol; 2014 Jul; 32(20):2151-8. PubMed ID: 24888815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up after treatment for breast cancer: Practical guide to survivorship care for family physicians.
    Sisler J; Chaput G; Sussman J; Ozokwelu E
    Can Fam Physician; 2016 Oct; 62(10):805-811. PubMed ID: 27737976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis.
    Nechuta S; Chen WY; Cai H; Poole EM; Kwan ML; Flatt SW; Patterson RE; Pierce JP; Caan BJ; Ou Shu X
    Int J Cancer; 2016 May; 138(9):2088-97. PubMed ID: 26606746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Care, Including Survivorship Care Plans.
    Hershman DL; Ganz PA
    Adv Exp Med Biol; 2015; 862():255-69. PubMed ID: 26059941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Health: Breast Cancer Survivorship.
    Rosenblatt P
    FP Essent; 2020 Sep; 496():26-34. PubMed ID: 32902244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of BRCA1/2 mutation testing among young survivors of breast cancer.
    Kehl KL; Shen C; Litton JK; Arun B; Giordano SH
    Breast Cancer Res Treat; 2016 Jan; 155(1):165-73. PubMed ID: 26706041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors.
    Harputluoglu H; Dizdar O; Karaahmet F; Altundag K
    Breast Cancer Res Treat; 2008 Aug; 110(3):541. PubMed ID: 17851754
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes and recurrence patterns according to breast cancer subtypes in Korean women.
    Lee Y; Kang E; Lee AS; Baek H; Kim EK; Park SY; Kim JH; Kim YJ; Kim SH; Kim IA; Eom KY; Kim SW
    Breast Cancer Res Treat; 2015 May; 151(1):183-90. PubMed ID: 25893592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral synchronous breast cancer developed as metachronous malignancy after therapy of other primaries.
    Kurzyński M; Mituś J; Kołodziej-Rzepa M; Sas-Korczyńska B
    Ginekol Pol; 2018; 89(5):235-239. PubMed ID: 30084474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.